Current concepts in the management of urinary candidosis.
Persistent Candiduria may represent significant urinary infection which has the potential for inducing obstructive uropathy and/or renal abscesses. Urine candidal colony counts, serological and radiographic studies will differentiate colonization from infection. Initial treatment may involve correction of iatrogenic factors such as removal of catheters, stopping antibacterial antibiotics and improvement of the patient's nutritional status. Persistence of funguria will require irrigations of the urinary system with antifungal agents and/or the use of systemic antifungal therapy.
D000287:Administration, Topical; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D014165:Transfer Factor / Q000008:administration & dosage; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000188:drug therapy; D014567:Urography
D000935:Antifungal Agents; D007093:Imidazoles; D014165:Transfer Factor; D009761:Nystatin; D000666:Amphotericin B; D005437:Flucytosine